| Literature DB >> 22082355 |
Ioanna Lola1, Stamatina Levidiotou, Anastasios Petrou, Helen Arnaoutoglou, Efstratios Apostolakis, George S Papadopoulos.
Abstract
BACKGROUND: Nosocomial infections after cardiac surgery represent serious complications associated with substantial morbidity, mortality and economic burden. This study was undertaken to evaluate the frequency, characteristics, and risk factors of microbiologically documented nosocomial infections after cardiac surgery in a Cardio-Vascular Intensive Care Unit (CVICU).Entities:
Mesh:
Year: 2011 PMID: 22082355 PMCID: PMC3223138 DOI: 10.1186/1749-8090-6-151
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Patients' characteristics.
| Characteristic | Patients | Percentage |
|---|---|---|
| Male | 133 | 77.3% |
| Female | 39 | 22.7% |
| Diabetes mellitus | 59 | 34.3% |
| Arterial hypertension | 118 | 68.6% |
| Chronic obstructive pulmonary disease | 22 | 12.8% |
| Chronic renal failure | 11 | 6.4% |
| Peripheral vascular disease | 23 | 13.4% |
| Stroke | 19 | 11% |
| Unstable angina | 35 | 20.3% |
| Recent myocardial infarction (within 90 days) | 46 | 26.7% |
| Older myocardial infarction | 31 | 18% |
| Pulmonary hypertension | 2 | 1.2% |
| Hyperlipidemia | 45 | 26.2% |
| Smoking | 69 | 40.1% |
| Alcohol abuse | 13 | 7.6% |
Intraoperative and postoperative data, perioperative transfusion.
| Intraoperative and postoperative data | Values |
|---|---|
| Duration of anesthesia (hours) | 6,35 ± 1,69 |
| Duration of extra-corporeal circulation (min) | 146.94 ± 55.14 |
| Ischemia time (min) | 109.27 ± 45.97 |
| Degree of hypothermia (οC) | 30.27 ± 1.61 |
| Emergency operation | 11 (6.4%) |
| Intra-aortic balloon pump (IABP) | 18 (10.5%) |
| Duration of mechanical ventilation (days) | 1.9 ± 4.23 |
| Re-intubation | 22 (12.8%) |
| Tracheotomy | 8 (4.7%) |
| Enteral nutrition for >10 days | 5 (2.9%) |
| Parenteral nutrition for >10 days | 6 (3.5%) |
| Re-operation | 13 (7.6%) |
| Complications in the CVICU | 44 (25.6%) |
| Re-admission to the CVICU | 20 (11.6%) |
| Length of stay in the CVICU (days) | 4.23 ± 6.4 |
| N of RBC units transfused | 4.37 ± 2.9 |
| N of FFP units transfused | 4.36 ± 3.8 |
| N of PLT units transfused | 5.85 ± 5.1 |
CVICU: cardio-vascular intensive care unit
Site of infections, number, percentage and incidence of infections in the studied 172 patients.
| Site of infection | N, % | Incidence |
|---|---|---|
| Bacteremia | 9 (30%) | 5.23% |
| Sternotomy site infection | 8 (26.7%) | 4.65% |
| Infection of vascular catheters | 5 (16.7%) | 2.90% |
| Pneumonia | 4 (13.3%) | 2.32% |
| Mediastinitis | 1 (3.3%) | 0.58% |
| Surgical site infection, other than sternotomy | 1 (3.3%) | 0.58% |
| Infection of the intra-aortic balloon pump (IABP) | 1 (3.3%) | 0.58% |
| Urinary tract infection | 1 (3.3%) | 0.58% |
| 30 (100%) | 17.42% |
Isolated pathogens and their resistance phenotype.
| Type of microorganism | Ν, (%) | Number of isolates/Resistance phenotype |
|---|---|---|
| 8 (26.7%) | 4/MRSE, 4/MSSE | |
| 2 (6.7%) | 1/MRSA, 1/MSSA | |
| 2 (6.7%) | 2/MRSH | |
| 2 (6.7%) | 2/VSE | |
| 1 (3.3%) | 1/VSE | |
| 8 (26.7%) | 8/MBL(-) | |
| 2 (6.7%) | 2/MBL(-) | |
| 3 (10%) | 1/ESBL(-), 2/ESBL(+) | |
| 1 (3.3%) | 1/ESBL(+) | |
| 1 (3.3%) | 1/ESBL(-) | |
| 30 (100%) |
MRSE: methicillin-resistant S. epidermidis; MSSE: methicillin-susceptible S. epidermidis; MRSA: methicillin-resistant S. aureus; MSSA: methicillin-susceptible S. aureus; MRSH: methicillin-resistant S. haemolyticus; VSE: vancomycin-susceptible Enterococcus; ESBL: extended-spectrum β-lactamase; MBL: metallo-β-lactamase.
Type of microorganisms per infection site and their respective resistance phenotype.
| Site of infection | Type of microorganism | Infections | Number of isolates/Resistance phenotype |
|---|---|---|---|
| 3 | 3/MBL(-) | ||
| 1 | 1/MBL(-) | ||
| 5 | 3/MRSE, 2/MSSE | ||
| 1 | 1/VSE | ||
| 1 | 1/MBL(-) | ||
| 1 | 1/MBL(-) | ||
| 1 | 1/MRSA | ||
| 1 | 1/MSSA | ||
| 2 | 1/MRSE, 1/MSSE | ||
| 1 | 1/MRSH | ||
| 3 | 3/MBL(-) | ||
| 1 | 1/ESBL(-) | ||
| 1 | 1/ESBL(-) | ||
| 1 | 1/VSE | ||
| 1 | 1/MRSH | ||
| 1 | 1/VSE | ||
| 1 | 1/MBL(-) | ||
| 1 | 1/ESBL(+) | ||
| 1 | 1/ESBL(+) | ||
| 1 | 1/MSSE | ||
| 1 | 1/ESBL(+) |
MRSE: methicillin-resistant S. epidermidis; MSSE: methicillin-susceptible S. epidermidis; MRSA: methicillin-resistant S. aureus; MSSA: methicillin-susceptible S. aureus; MRSH: methicillin-resistant S. haemolyticus; VSE: vancomycin-susceptible Enterococcus; ESBL: extended-spectrum β-lactamase; MBL: metallo-β-lactamase.
Univariate logistic regression analysis of the association of various factors with development of infection.
| Examined factors | With | Without infection | |
|---|---|---|---|
| Diabetes mellitus* | 13 (22%) | 46 (78%) | |
| Arterial hypertension | 18 (15.3%) | 100 (84.7%) | 0.469 |
| COPD | 4 (18.2%) | 18 (81.8%) | 0.542 |
| Chronic renal failure | 5 (45.5%) | 6 (54.5%) | 0.127 |
| Peripheral vascular disease | 5 (21.7%) | 18 (78.3%) | 0.253 |
| Stroke | 5 (26.3%) | 14 (73.7%) | 0.109 |
| Unstable angina | 6 (17.1%) | 29 (82.9%) | 0.543 |
| Recent myocardial infarction | 5 (10.9%) | 41 (89.1%) | 0.483 |
| Older myocardial infarction | 6 (19.4%) | 25 (80.6%) | 0.341 |
| Pulmonary hypertension | 1 (50%) | 1 (50%) | 0.195 |
| Hyperlipidemia | 7 (15.6%) | 38 (84.4%) | 0.718 |
| Smoking | 13 (18.8%) | 56 (81.2%) | 0.135 |
| Alcohol abuse | 1 (7.7%) | 12 (92.3%) | 0.506 |
| Duration of anesthesia (hours) | 6.78 ± 1.94 | 6.28 ± 1.65 | 0.181 |
| Extra-corporeal circulation (min) | 138.87 ± 85.88 | 119.27 ± 72.67 | 0.234 |
| Ischemia time (min) | 101,75 ± 61,76 | 88,95 ± 58,19 | 0.322 |
| Degree of hypothermia (°C) | 23.33 ± 12.40 | 25.40 ± 11.38 | 0.416 |
| Emergency operation | 5 (45.5%) | 6 (54.5%) | 0.545 |
| Intra-aortic balloon pump (IABP) | 5 (27.8%) | 13 (72.2%) | 0.069 |
| Duration of mechanical ventilation* | 5.42 ± 10.31 | 1.34 ± 1.35 | |
| Re-intubation | 11 (50%) | 11 (50%) | 0.337 |
| Tracheotomy | 7 (87.5%) | 1 (12.5%) | 0.133 |
| Enteral nutrition for >10 days | 5 (100%) | 0 | 0.999 |
| Parenteral nutrition for >10 days | 6 (100%) | 0 | 0.328 |
| Re-operation | 7 (53.8%) | 6 (46.2%) | 0.310 |
| Complications in the CVICU* | 19 (43.2%) | 25 (56.8%) | |
| Re-admission to the CVICU* | 12 (60%) | 8 (40%) | |
| Total CVICU length of stay | 12.54 ± 12.60 | 2.84 ± 2.60 | 0.519 |
| CVICU length of stay >15 days | 8 (80%) | 2 (20%) | 0.519 |
| N of RBC units transfused | 6.79 ± 4.45 | 3.97 ± 2.35 | |
| N of FFP units transfused | 7.00 ± 6.39 | 3.93 ± 2.96 | |
| N of PLT units transfused | 8.13 ± 7.45 | 5.49 ± 4.57 |
*Variables significantly associated with infection (p value < 0.05).
COPD: Chronic obstructive pulmonary disease; CVICU: cardio-vascular intensive care unit
Statistically significant factors according to multiple logistic regression analysis associated with a higher risk to acquire infection.
| Risk Factor | Odds ratio | Confidence Interval | p Value |
|---|---|---|---|
| Diabetes mellitus | 5.92 | 1.56-22.42 | 0.009 |
| Duration of mechanical ventilation (days) | 1.30 | 1.005-1.69 | 0.046 |
| Complications in the CVICU | 18.66 | 3.36-103.61 | 0.001 |
| Re-admission to the CVICU | 8.59 | 2.02-36.45 | 0.004 |
CVICU: cardio-vascular intensive care unit